These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20616735)

  • 1. Evaluation and management of hyperlipidemia in children and adolescents.
    Iughetti L; Bruzzi P; Predieri B
    Curr Opin Pediatr; 2010 Aug; 22(4):485-93. PubMed ID: 20616735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of dyslipidemia in adults.
    Ahmed SM; Clasen ME; Donnelly JE
    Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
    Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
    J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hyperlipidemia in pediatrics.
    Daniels SR
    Curr Opin Cardiol; 2012 Mar; 27(2):92-7. PubMed ID: 22233976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 9. New strategies in the treatment of dyslipidemia: do we know how?
    Vrablík M; Ceska R
    Semin Vasc Med; 2004 Aug; 4(3):305-10. PubMed ID: 15630630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice guidelines for the management of dyslipidemia.
    Nichols N
    Can J Cardiovasc Nurs; 2004; 14(2):7-10. PubMed ID: 15230023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid screening and cardiovascular health in childhood.
    Daniels SR; Greer FR;
    Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina.
    Bertoni AG; Bonds DE; Steffes S; Jackson E; Crago L; Balasubramanyam A; Chen H; Goff DC
    Am Heart J; 2006 Oct; 152(4):785-92. PubMed ID: 16996859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary disorders of lipid metabolism in pediatrics.
    Kwiterovich PO
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():727-38. PubMed ID: 18317444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia and lipid-lowering therapy in the elderly.
    Deedwania P; Volkova N
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):453-63. PubMed ID: 15889973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
    Nordøy A
    Minerva Med; 2002 Oct; 93(5):357-63. PubMed ID: 12410168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia in adolescents.
    Kanani PM; Sperling MA
    Adolesc Med; 2002 Feb; 13(1):37-52, v-vi. PubMed ID: 11841954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
    Frohlich J; Fodor G; McPherson R; Genest J; Langner N
    Can J Cardiol; 1998 Apr; 14 Suppl A():17A-21A. PubMed ID: 9594929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Cheng AY; Leiter LA
    Curr Opin Cardiol; 2006 Jul; 21(4):400-4. PubMed ID: 16755211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.